Medical Narration
Description
Vocal Characteristics
Language
EnglishVoice Age
Young Adult (18-35)Accents
North American (General)Transcript
Note: Transcripts are generated using speech recognition software and may contain errors.
myopathy is a potential serious side effect of H M G Co. A. Reductase inhibitors. Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobin urea have been reported with a tour of a Stayton and other drugs in this class, a tour of the state and therapy should be discontinued if myopathy is diagnosed or suspected, or if a patient develops marked elevations in CPK or rhabdomyolysis myopathy, defined as muscle aches or muscle weakness. In conjunction with increases in CREA teen fuss folk ****, CBK values more than 10 times the upper limit of normal. You Ln should be considered in any patient with diffuse my allergist muscle tenderness or weakness and or marked elevation of CBK. Patients should be advised to report promptly unexplained muscle pain, tenderness or weakness, particularly if accompanied by Malays or fever. A tour of a state and maybe contra indicated or temporarily withheld in conditions that can cause decreased renal profusion. Since renal failure is possible if atorvastatin induced myopathy and rhabdomyolysis occurs, predisposing risk factors for myopathy and or rhabdomyolysis include renal dysfunction, hypertension, sepsis or severe acute infection. Severe or uncontrolled endocrine disease, such as uncontrolled hypothyroidism, acute electrolyte imbalance or uncontrolled seizure disorder. Major surgery and trauma. The risk of developing myopathy is also increased when H M G Co. A. Reductase inhibitors, are used in combination with selected drugs. For example, five rates and others. A tour of a Stayton should be used with caution in organ transplant and other patients receiving immuno suppressant therapy. Such a cyclist boring because of an increased risk of rhabdomyolysis and renal failure. Lower initial and maximum doses of a tortoise Stayton are recommended for such patients. Renal disease has no influence on a tour of estate and plasma concentrations or LDL cholesterol reductions. Dosage adjustments are not needed in patients with renal impairment.